Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kuniko Masuyama is active.

Publication


Featured researches published by Kuniko Masuyama.


Free Radical Biology and Medicine | 2002

Ebselen suppresses late airway responses and airway inflammation in guinea pigs

Minjie Zhang; Akihiro Nomura; Yoshiyuki Uchida; Hiroaki Iijima; Tohru Sakamoto; Yukio Iishii; Yuko Morishima; Mie Mochizuki; Kuniko Masuyama; Kuniyoshi Hirano; Kiyohisa Sekizawa

Although ebselen, a seleno-organic compound, inhibits inflammation in various animal models, its efficacy as an anti-asthma drug remains to be clarified. In this study, we investigated the inhibitory effect of ebselen on a guinea pig asthma model. Ebselen was orally administered at dosages of 1-20 mg/kg 2 h before an ovalbumin (OA) challenge, and then airway responses, airway inflammation, the generation of superoxide, H(2)O(2), and nitrotyrosine, and the induction of inducible nitric oxide synthase (iNOS) were evaluated. Sensitized animals challenged with OA aerosol showed dual airflow limitations, i.e., immediate and late airway responses (IAR and LAR). Ebselen significantly inhibited LAR at dosages greater than 10 mg/kg, but did not inhibit IAR at any dosage. Bronchoalveolar lavage (BAL) examination showed that airway inflammation was significantly suppressed by ebselen at 10 mg/kg. The generation of superoxide and H(2)O(2) occurred on endothelial cells of LAR bronchi, and was inhibited by 10 mg/kg of ebselen. Superoxide generation was inhibited by diphenyleneiodonium chloride (DPI), a NAD(P)H oxidase inhibitor, but not by allopurinol, a xanthine oxidase inhibitor. Immunoreactivities for iNOS and nitrotyrosine were also observed on endothelial cells of LAR bronchi and were abolished in ebselen-treated animals. The present findings suggest that ebselen can be applied as a new therapeutic agent for asthma. The possible mechanisms by which ebselen inhibits LAR likely involve suppression of oxidant formation and iNOS induction in endothelial cells.


Clinical & Experimental Allergy | 2002

Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor-bβ

Akihiro Nomura; Yoshiyuki Uchida; T. Sakamoto; Yukio Ishii; Kuniko Masuyama; Yuko Morishima; Kuniyoshi Hirano; Kiyohisa Sekizawa

Background Collagen type I is one of the major deposits in thickening of the reticular basement membrane of asthma.


Lung | 2000

Ebselen Decreases Ozone-Induced Pulmonary Inflammation in Rats

Yukio Ishii; K. Hashimoto; Kuniyoshi Hirano; Yuko Morishima; Mie Mochizuki; Kuniko Masuyama; Akihiro Nomura; T. Sakamoto; Yoshiyuki Uchida; Masaru Sagai; Kiyohisa Sekizawa

Abstract. We studied the effects of ebselen on rat lung inflammatory responses against ozone exposure. Rats were treated with ebselen every 12 h from 1 h before a single 4-h exposure to 2 ppm ozone. Treatment with ebselen (10 mg/kg) significantly decreased pulmonary inflammation as indicated by the albumin concentration and the number of neutrophils in the bronchoalveolar lavage fluid 18 h after the ozone exposure. Although treatment with ebselen did not alter the macrophage expression of inducible nitric oxide synthase after the ozone exposure, it did markedly inhibit the nitration reaction of tyrosine residues, suggesting that ebselen scavenges peroxynitrite during ozone-induced pulmonary inflammation. Treatment with ebselen also enhanced the pulmonary expression of both copper, zinc, and manganous superoxide dismutases at the same time point. These enzymes may also contribute to a decrease in the formation of peroxynitrite by lowering the concentration of superoxide. Thus, ebselen represents a useful compound for protecting against certain acute lung injuries by modulating the oxidant-related inflammatory process.


In Vitro Cellular & Developmental Biology – Animal | 2001

Maintenance of the differentiated type II cell characteristics by culture on an acellular human amnion membrane

Tohru Sakamoto; Kuniyoshi Hirano; Yuko Morishima; Kuniko Masuyama; Yukio Ishii; Akihiro Nomura; Yoshiyuki Uchida; Morio Ohtsuka; Kiyohisa Sekizawa

SummaryWe have developed a culture system for guinea pig alveolar type II cells using an epithelium-denuded human amnion membrane as a substratum. The differentiated morphology was maintained for 3 wk by both air-interface feeding and immersion feeding when type II cells were cultured on the basement membrane side of the amnion with fibroblasts on the opposite side (coculture). Functionally, high levels of surfactant protein, B (SP-B) and C (SP-C) messenger ribonucleic acids (mRNAs) were expressed even after the 3-wk cultivation and surfactant protein A mRNA was detected on day 10 of the culture. The differentiation was also maintained when fibroblasts were cultured on lower chambers of the culture plates (separate culture). In contrast, culture of type II cells without fibroblasts (monoculture) could not preserve the mature morphology. When the monoculture was supplemented with keratinocyte growth factor or hepatocyte growth factor, a monolayer of rather cuboidal type II cells with apical microvilli was maintained. However, the percent area of lamellar bodies in these cells was significantly less than that in freshly isolated type II cells, and mRNA expressions of SP-B and SP-C were also considerably suppressed. These findings suggest that other growth factors or combinations of these factors are necessary for the maintenance of the differentiated phenotype. As substratum, a permeable collagen membrane or a thin gel layer of Engelbreth-Holm-Swarm mouse sarcoma extracts did not preserve the mature characteristics. This culture system using an acellular human amnion membrane may provide novel models for research in type II cells.


American Journal of Respiratory Cell and Molecular Biology | 2001

Triggering the Induction of Myofibroblast and Fibrogenesis by Airway Epithelial Shedding

Yuko Morishima; Akihiro Nomura; Yoshiyuki Uchida; Yoshiko Noguchi; Tohru Sakamoto; Yukio Ishii; Yukio Goto; Kuniko Masuyama; Min Jie Zhang; Kuniyoshi Hirano; Mie Mochizuki; Morio Ohtsuka; Kiyohisa Sekizawa


American Journal of Respiratory Cell and Molecular Biology | 2000

Dislocation of E-cadherin in the airway epithelium during an antigen-induced asthmatic response.

Yukio Goto; Yoshiyuki Uchida; Akihiro Nomura; Tohru Sakamoto; Yukio Ishii; Yuko Morishima; Kuniko Masuyama; Kiyohisa Sekizawa


American Journal of Respiratory and Critical Care Medicine | 2001

Exposure to Diesel Exhaust Exacerbates Allergen-induced Airway Responses in Guinea Pigs

K. Hashimoto; Yukio Ishii; Yoshiyuki Uchida; Toru Kimura; Kuniko Masuyama; Yuko Morishima; Kuniyoshi Hirano; Akihiro Nomura; Tohru Sakamoto; Hirohisa Takano; Masaru Sagai; Kiyohisa Sekizawa


Journal of Applied Physiology | 2002

Involvement of thromboxane A2 in airway mucous cells in asthma-related cough

Anbo Xiang; Yoshiyuki Uchida; Akihiro Nomura; Hiroaki Iijima; Tohru Sakamoto; Yukio Ishii; Yuko Morishima; Kuniko Masuyama; Minjie Zhang; Kuniyoshi Hirano; Kiyohisa Sekizawa


Toxicology and Applied Pharmacology | 2000

Early Molecular and Cellular Events of Oxidant-Induced Pulmonary Fibrosis in Rats

Yukio Ishii; Kuniyoshi Hirano; Yuko Morishima; Kuniko Masuyama; Yukio Goto; Akihiro Nomura; Tohru Sakamoto; Yoshiyuki Uchida; Masaru Sagai; Kiyohisa Sekizawa


The Journal of Allergy and Clinical Immunology | 2003

Sputum E-cadherin and asthma severity.

Kuniko Masuyama; Yuko Morishima; Yukio Ishii; Akihiro Nomura; Tohru Sakamoto; Toru Kimura; Mie Mochizuki; Yoshiyuki Uchida; Kiyohisa Sekizawa

Collaboration


Dive into the Kuniko Masuyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaru Sagai

Aomori University of Health and Welfare

View shared research outputs
Researchain Logo
Decentralizing Knowledge